Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy
Launched by CLINICAL HOSPITAL CENTER, SPLIT · Nov 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different methods of treating a serious eye condition called rhegmatogenous retinal detachment, which occurs when the inner layers of the retina separate due to fluid entering through a tear. The trial focuses on a specific procedure known as pneumatic retinopexy, where a gas bubble is injected into the eye to help reattach the retina. Participants in this study will have one of two approaches to close the retinal tear: freezing the area (cryotherapy) or using a laser (laser photocoagulation).
To be eligible for this trial, patients must have a retinal tear located in the upper half of the retina and no more than two clock hours of tears. Those with tears in the lower half, multiple tears, or certain other eye conditions are not eligible. During the procedure, participants will receive local anesthesia and will need to maintain a specific head position for several days afterward to ensure the gas bubble presses against the tear effectively. This method is less invasive than other treatments and generally has fewer risks, but successful recovery relies on following the doctor's post-surgery instructions closely.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with rhegmatogenous retinal detachment with one or more tears within two clock hours, limited to the upper half of the retina
- Exclusion Criteria:
- • Patients with tears in the lower half of the retina
- • Patients with multiple retinal tears covering more than two clock hours
- • Patients with developed proliferative vitreoretinopathy
- • Patients with vitreous hemorrhage
- • Patients with opaque optical media due to other conditions that could obstruct a detailed fundus examination or the procedure itself
- • Patients unable to follow postoperative head positioning instructions
- • Patients under age of 18 years
About Clinical Hospital Center, Split
Clinical Hospital Center Split is a leading medical institution in Croatia, dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the center collaborates with a diverse team of healthcare professionals and researchers to conduct rigorous clinical studies across various medical disciplines. Committed to enhancing treatment options and improving patient outcomes, Clinical Hospital Center Split adheres to the highest ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Split, , Croatia
Patients applied
Trial Officials
Ivan Borjan, MD
Principal Investigator
Clinical Hospital Center, Split
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported